SFM
VYGR icon

Sphera Funds Management’s Voyager Therapeutics VYGR Stock Holding History

Sphera Funds Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
427,554
-42,207
-9% -$160K 0.2% 94
2026
Q1 		$1.81M Buy
469,761
+130,000
+38% +$512K 0.29% 82
2025
Q4 		$1.34M Buy
339,761
+140,000
+70% +$619K 0.26% 83
2025
Q3 		$933K Buy
+199,761
New +$723K 0.2% 96

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sphera Funds Management's VYGR Position: Q2 2026 in Review

Sphera Funds Management reduced its Voyager Therapeutics (VYGR) stake by 9% in Q2 2026, selling an estimated $160K and leaving 427,554 shares worth $1.5M. The position accounts for 0.2% of the portfolio, ranked #94.

Sphera Funds Management first reported a position in VYGR in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.81M in Q1 2026. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Sphera Funds Management held 427,554 shares of Voyager Therapeutics worth $1.5M as of Q2 2026.
  • Sphera Funds Management sold 42,207 Voyager Therapeutics shares in Q2 2026, an estimated $160K.
  • Voyager Therapeutics made up 0.2% of Sphera Funds Management's portfolio in Q2 2026, its #94 holding.
  • Sphera Funds Management first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Sphera Funds Management's Voyager Therapeutics position peaked at $1.81M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.